EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Correlation between erythropoietin sensitivity and parameters of iron status in hemodialysis patients



Correlation between erythropoietin sensitivity and parameters of iron status in hemodialysis patients



Nephrology Dialysis Transplantation 15(9): A157, September




(PDF emailed within 1 workday: $29.90)

Accession: 034654121

Download citation: RISBibTeXText



Related references

Diagnostic power of iron status markers in detecting functional iron deficiency in hemodialysis patients on erythropoietin. Nephrology Dialysis Transplantation 15(9): A157, September, 2000

Serum erythropoietin concentrations and iron status in patients on chronic hemodialysis. Clinical Chemistry 38(2): 199-203, 1992

Iron status and low dose intravenous FeGluconate in hemodialysis patients on maintenance erythropoietin. Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 272A, Sept, 1998

The influence of aluminum and iron status on serum erythropoietin concentrations in hemodialysis patients. Nephrology Dialysis Transplantation 10(6): 1050, 1995

Changes of endogenous erythropoietin level and iron status during a 30-month hemodialysis treatment of a group of patients. International Urology and Nephrology 33(3): 541-546, 2002

Changes of endogenous erythropoietin level and iron status during a 30-month hemodialysis treatment of a group of patients. International Urology and Nephrology 33(3): 541-546, 2001

Sensitivity and specificity of transferrin saturation and serum ferritin as markers of iron status after intravenous iron dextran in hemodialysis patients. Renal Failure 19(6): 781-788, 1997

Sensitivity and specificity of transferrin saturation and serum ferritin as markers of iron status after intravenous iron dextran in hemodialysis patients. Renal Failure 19(6): 781-788, 1998

Ferroportin in monocytes of hemodialysis patients and its associations with hepcidin, inflammation, markers of iron status and resistance to erythropoietin. International Urology and Nephrology 46(1): 161-167, 2014

Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum. Gaoxiong Yi Xue Ke Xue Za Zhi 7(3): 126-135, 1991

Intravenous iron reduces erythropoietin use and improves iron indices in hemodialysis patients with functional iron deficiency. Journal of the American Society of Nephrology 14(Abstracts Issue): 706A, November, 2003

Effect of human recombinant erythropoietin (r-EPO) on behavior of iron status parameters in patients with chronic renal failure treated with dialysis. Polskie Archiwum Medycyny Wewnetrznej 92(3): 207-215, 1994

Antioxidant status and lipid peroxidation in hemodialysis patients undergoing erythropoietin and erythropoietin-vitamin E combined therapy. Free Radical Research 31(3): 211-216, 1999